George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksS & U Regulatory News (SUS)

Share Price Information for S & U (SUS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,910.00
Bid: 1,890.00
Ask: 1,910.00
Change: 20.00 (1.06%)
Spread: 20.00 (1.058%)
Open: 1,910.00
High: 1,910.00
Low: 1,890.00
Prev. Close: 1,890.00
SUS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement and Notice of Results

10 Feb 2022 07:00

RNS Number : 2016B
S & U PLC
10 February 2022
 

 

10 February 2022

 

S&U plc

("S&U" or "the Group")

 

TRADING STATEMENT AND NOTICE OF RESULTS

 

S&U plc, the specialist motor finance and property bridging lender, today issues its trading update for the period from its trading statement of 9 December 2021 to the Group's year end on 31 January 2022. S&U's full year results will be announced on 29 March 2022.

 

Founded on an excellent collections and debt quality performance and the expected rebound in sales as the Covid pandemic gradually abates, S&U's profit before tax for the year is now set to exceed current consensus expectations. Whilst both political and economic uncertainty still clouds the horizon for the UK consumer, and supply shortages still inhibit the used car market, we confidently expect 2022 to gradually see a full rebound to normal motor sales conditions.

 

Meanwhile, the plans and foundations are in place for continued, accelerated and sustainable growth both at Advantage, our motor finance lender, and at Aspen, our property bridging business.

 

Motor Finance

As the economy recovers and consumer confidence gradually returns, Advantage's focus on good customer relations, responsible underwriting and sensible cost control is reaping its reward, as well as providing a firm base for further growth this year. Annualised live collection rates were 93% of due - themselves above budget and 9% ahead of last year - including an excellent live collection rate of 98% in January 2022. Lower bad debts and voluntary terminations than anticipated mean we expect a much lower than normal impairment charge this year. This will see profit before tax more than double last year's £17.2m, when the Covid-related impairment charge was much higher than normal (prior year impairment charges: £36.0m for year ended 31 January 2021 and £16.5m for year ended 31 January 2020). This means that Advantage's profit over the past two years of the pandemic is anticipated to be only slightly below our excellent pre-Covid level - a remarkable achievement.

 

Whilst supply constraints in the used car market remain, driven by new car production which is 20-25% down on last year, the consequent constraint on sales is expected to gradually reverse from the second quarter of 2022. Even so, as anticipated, Advantage has achieved net loan advances totalling over £140m in our financial year to 31 January 2022 (2021: £102.6m), a trend which is expected to see a return to normal transaction levels and growth over the next two years.

 

Advantage is already implementing many of the customer and sales initiatives announced in our last trading statement. The self-service portal for customers is driving both higher collections and levels of customer satisfaction. Our investment in Digital Marketing and brand development has been underpinned by the appointment of a new Head of Marketing. Projects with our specialist technology partners will both streamline and strengthen underwriting and open up new fields of opportunity with consolidators and dealer groups.

 

Further, Advantage is developing a carbon neutral footprint. It has extended its product range and begun to finance electric vehicles for the first time.

 

As a result, Advantage is poised for a profitable new era of expansion, firmly rooted in an admirable record during the pandemic, excellent debt quality and imaginatively expanded routes to market.

 

Property Bridging

Aspen Bridging is benefiting from both a thriving UK property market and from the growing expertise and experience of its people. House prices in December 2021 rose 7.4% according to Zoopla, followed by a reported 11% increase in January 2022. Equally important, residential transaction levels have recovered strongly in January 2022, being the highest since 2007. This has been reflected in Aspen achieving 28 deals totalling over £20m of gross lending in the two month period.

 

Credit quality remains strong with continued low levels of default and most customers settling within or just beyond the normal term of the loan.

 

Aspen is building on this success by selective recruitment, the introduction of a new Bridge to Let product and by refining its product range. As a result, its current net receivables loan book of c£64m is the highest ever and its record profitability this year has greatly exceeded expectations. We anticipate further record results in the year to come.

 

Funding

Reflecting S&U's historically strong treasury position and the excellent collections performances mentioned above, Group borrowing at year end is £114m (2021: £99m). This makes Group gearing an estimated 55%, the same as last year, and with Group facilities standing at £180m, gives ample room for the growth we anticipate in both businesses this year.

 

Dividend

Both current trading and our positive view of S&U's prospects for sustainable growth, leads the Board to recommend a second interim dividend this year of 36p per ordinary share (2021: 25p). This will be paid on 11 March 2022 to those shareholders on the register on 18 February 2022.

 

Commenting on the Group's performance and outlook, Anthony Coombs, S&U Chairman, said:

 

"Although exceptional factors have benefited the Group's profitability this year, in the years to come the ongoing quality of our customer lending, the strength of our finances and our investment in the growth of our routes to market will underpin S&U's return to the levels and rates of profit growth experienced before the pandemic. I therefore remain very confident in our future prospects."

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR. The person responsible for making this announcement is the Company Secretary.

 

 

For further information, please contact:

 

S&U

Anthony Coombs, Chairman 0121 705 7777

 

Newgate Communications

Bob Huxford, Axaule Shukanayeva, Megan Kovach 020 7653 9848

 

Peel Hunt

Adrian Trimmings, Andrew Buchanan, Rishi Shah 020 7418 8900

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUPUBPPUPPGCB
Date   Source Headline
9th Apr 20247:00 amRNSPreliminary Unaudited FY Results to 31 Jan 24
25th Mar 20247:00 amRNSResults Presentations for Analysts and Investors
9th Feb 20247:00 amRNSTrading Statement and Notice of Results
1st Feb 20242:30 pmRNSNotice of Trading Update
11th Jan 20242:00 pmRNSDirector/PDMR Shareholding
12th Dec 20237:00 amRNSTrading Statement to 11 December 2023
31st Oct 20232:29 pmRNSDirector/PDMR and PCA Shareholding
5th Oct 20237:00 amRNSDirectorate Change
3rd Oct 20237:00 amRNSInterim Results for the 6 months to 31 July 2023
4th Sep 20237:00 amRNSNotice of Results and Investor Presentation
10th Aug 20237:00 amRNSTrading Update and Notice of Results
25th Jul 202311:34 amRNSDirector/PDMR Shareholding
17th Jul 20233:34 pmRNSDirector/PDMR Shareholding
26th May 20234:38 pmRNSDirector/PDMR Shareholding
25th May 202312:43 pmRNSResult of AGM
25th May 20237:00 amRNSAGM Statement and Trading Update
25th Apr 20232:00 pmRNSAnnual Report and Accounts
25th Apr 202311:48 amRNSDirector/PDMR Shareholding
20th Apr 20237:00 amRNSMello Investor Presentation
6th Apr 20234:08 pmRNSAnnouncement of Annual Report and Accounts
28th Mar 20234:35 pmRNSPrice Monitoring Extension
28th Mar 20237:00 amRNSPreliminary Results
23rd Mar 20234:35 pmRNSPrice Monitoring Extension
28th Feb 20237:00 amRNSResults Presentations for Analysts and Investors
14th Feb 20232:00 pmRNSAppointment of Executive Director
9th Feb 20237:00 amRNSTrading Statement and Notice of Results
8th Dec 20227:00 amRNSTrading Statement
27th Sep 20227:00 amRNSInterim Results
30th Aug 20227:00 amRNSResults Presentations for Analysts and Investors
18th Aug 20224:36 pmRNSPrice Monitoring Extension
10th Aug 20227:00 amRNSTrading Update and Notice of Results
3rd Aug 20224:40 pmRNSSecond Price Monitoring Extn
3rd Aug 20224:35 pmRNSPrice Monitoring Extension
8th Jul 20225:06 pmRNSDirector/PDMR and PCA Shareholding
1st Jun 20227:00 amRNSTotal Voting Rights
26th May 202212:33 pmRNSResult of AGM
26th May 20227:00 amRNSAGM Statement and Trading Update
23rd May 20227:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
18th May 202211:30 amRNSOptions, Director/PDMR Shareholding, Voting Rights
13th May 20224:33 pmRNSDirector/PDMR Shareholding
5th May 20221:53 pmRNSDirector/PDMR Shareholding, Options, Voting Rights
26th Apr 20222:00 pmRNSAnnual Report and Accounts
4th Apr 20227:00 amEQSEdison Investment Research Limited: S&U (SUS): Seeing recovery and adapting to grow
4th Apr 20227:00 amRNSAnnual Report and Accounts
29th Mar 20227:00 amRNSPreliminary Results
9th Mar 20227:00 amRNSResults Presentations for Analysts and Investors
10th Feb 20227:00 amRNSTrading Statement and Notice of Results
17th Jan 20222:39 pmRNSAppointment of non-executive director
17th Jan 20222:33 pmRNSDirector/PDMR Shareholding
9th Dec 20217:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.